Publications

Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47

 65
Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47

Tags:

Previous Article

Opposing roles for AMPK in regulating distinct mitophagy pathways

Next Article

Gene replacement therapy for hereditary spastic paraplegia type 47

Related Posts

Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

Molecular design of a therapeutic LSD analogue with red...

 78

RNA G-quadruplexes form scaffolds that promote neuropathological a-synuclein aggregation

RNA G-quadruplexes form scaffolds that promote neuropat...

 77

Genome sequence analyses identify novel risk loci for multiple system atrophy

Genome sequence analyses identify novel risk loci for m...

 37